Zipnosis is a technology company.
Zipnosis has raised $22.0M across 3 funding rounds.
Zipnosis has raised $22.0M in total across 3 funding rounds.
Zipnosis has raised $22.0M in total across 3 funding rounds.
Zipnosis's investors include Arthur Ventures, Hyde Park Venture Partners, Tensility Venture Partners.
Zipnosis is a health tech company founded in 2008 that developed an asynchronous telemedicine platform enabling health systems to deliver branded virtual care clinics for urgent care, surgical care, occupational medicine, and more.[1][2][4][5] Its core product uses intelligent adaptive interviews to automate 99% of administrative work, allowing physicians to review and treat patients in under 89 seconds to 2 minutes—10 times faster than video or in-person visits—boosting provider capacity by 60% while increasing patient access.[1][2][3] Serving over 50 health systems like Ballad Health, SSM Health, and Allina Health, Zipnosis facilitated 4.5 million patient encounters with 3,500 physicians before its acquisition by Florence in May 2023, after which it integrated into Florence's omnichannel platform for hybrid virtual-physical care.[1][2][5]
The platform is device-agnostic, EMR-agnostic with HL7/FHIR integrations, and white-labeled for seamless embedding into health systems' workflows, prioritizing patient-provider efficiency over traditional synchronous models.[2][6]
Zipnosis was founded in 2008 in Minneapolis, Minnesota, by CEO Jon Pearce, emerging as a digital health pioneer in asynchronous virtual care amid growing demand for convenient, non-real-time telemedicine.[4][5] The idea stemmed from addressing healthcare's core constraint—provider time—by enabling virtual interactions for urgent care, surgical prep, occupational health, and respiratory issues, which gained traction during the COVID-19 pandemic for remote patient triage.[1][4] Early milestones included rapid scaling to support health systems with device-agnostic tech requiring only an internet connection, quick provider onboarding (under 1 hour), and flexible workflows with editable SOAP notes and patient education templates.[3][6]
By 2023, as a 60-person company with $23.73M raised, Zipnosis had proven pivotal through initiatives like "Healthcare’s Marketplace," a provider network dynamically matching patient demand to capacity across 24/7 nationwide resources.[3][5] This led to its all-cash acquisition by Florence in May 2023, enhancing Florence's patient intake tools with Zipnosis' async tech for broader clinical capacity management.[1][2][5]
Zipnosis rode the telehealth boom, particularly post-COVID, by pioneering asynchronous care to offload in-person bottlenecks, aligning with trends in hybrid care models that blend virtual triage with physical delivery.[1][4] Its timing capitalized on market forces like clinician shortages, rising patient demand for on-demand access, and payers' push for cost-efficient care (CMS/Medicaid/private insurance reimbursement).[2][6] By partnering with progressive health systems, it influenced the ecosystem through proven outcomes—higher accessibility, reduced costs, better outcomes—paving the way for integrated platforms like Florence's, which now enable omnichannel experiences across 40+ systems.[1][2]
This positioned Zipnosis as a key enabler in value-based care, reducing no-show rates and administrative burden while scaling virtual clinics amid digital health consolidation.[3][5]
Post-acquisition, Zipnosis' tech will fuel Florence's expansion into consumer-centric hybrid care, likely accelerating adoption in emergency departments and beyond as AI-driven async tools evolve.[1][2] Trends like AI workflow automation, nationwide provider networks, and payer incentives for efficient telehealth will shape its trajectory, potentially influencing 100M+ encounters by enhancing capacity in strained systems. Its legacy of prioritizing patients and providers positions it to drive broader industry shifts toward time-efficient, accessible care, building on its foundational role in modern telemedicine.
Zipnosis has raised $22.0M across 3 funding rounds. Most recently, it raised $3.0M Series B in August 2018.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Aug 1, 2018 | $3.0M Series B | Arthur Ventures, Hyde Park Venture Partners | |
| Jan 1, 2016 | $17.0M Series A | Arthur Ventures, Hyde Park Venture Partners, Tensility Venture Partners | |
| Nov 1, 2014 | $2.0M Seed | Arthur Ventures, Hyde Park Venture Partners |